ID30039A - Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya - Google Patents

Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya

Info

Publication number
ID30039A
ID30039A IDW00200101038A ID20011038A ID30039A ID 30039 A ID30039 A ID 30039A ID W00200101038 A IDW00200101038 A ID W00200101038A ID 20011038 A ID20011038 A ID 20011038A ID 30039 A ID30039 A ID 30039A
Authority
ID
Indonesia
Prior art keywords
control pharmaceutical
formulation
various units
units containing
control
Prior art date
Application number
IDW00200101038A
Other languages
English (en)
Indonesian (id)
Inventor
Torkel Gren
Anders Ringberg
Martin Wikberg
Randy J Wald
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30039(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of ID30039A publication Critical patent/ID30039A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW00200101038A 1998-11-11 1999-11-11 Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya ID30039A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (sv) 1998-11-11 1998-11-11 Therapeutic method and formulation

Publications (1)

Publication Number Publication Date
ID30039A true ID30039A (id) 2001-11-01

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101038A ID30039A (id) 1998-11-11 1999-11-11 Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya

Country Status (40)

Country Link
US (1) US6911217B1 (is)
EP (1) EP1128819B1 (is)
JP (1) JP3616011B2 (is)
KR (1) KR100467384B1 (is)
CN (1) CN1169522C (is)
AP (1) AP1323A (is)
AR (1) AR027815A1 (is)
AT (1) ATE247458T1 (is)
AU (1) AU762410B2 (is)
BG (1) BG65149B1 (is)
BR (1) BRPI9915142B8 (is)
CA (1) CA2350061C (is)
CZ (1) CZ299582B6 (is)
DE (1) DE69910604T2 (is)
DK (1) DK1128819T3 (is)
EA (1) EA005074B1 (is)
EE (1) EE05232B1 (is)
ES (1) ES2204193T3 (is)
GE (1) GEP20022833B (is)
HK (1) HK1040917B (is)
HR (1) HRP20010333B1 (is)
HU (1) HU226582B1 (is)
ID (1) ID30039A (is)
IL (1) IL142809A0 (is)
IS (1) IS2370B (is)
MA (1) MA25325A1 (is)
MY (1) MY122195A (is)
NO (1) NO331399B1 (is)
NZ (1) NZ511430A (is)
OA (1) OA11673A (is)
PL (1) PL195780B1 (is)
PT (1) PT1128819E (is)
RS (1) RS49891B (is)
SE (1) SE9803871D0 (is)
SI (1) SI1128819T1 (is)
SK (1) SK284758B6 (is)
TW (2) TWI222879B (is)
UA (1) UA57165C2 (is)
WO (1) WO2000027364A1 (is)
ZA (1) ZA200103575B (is)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2259012C (en) * 1996-07-19 2008-05-13 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE60021749T2 (de) * 1999-11-11 2006-04-20 Pfizer Health Ab Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
AU2003265680A1 (en) * 2002-08-28 2004-03-19 Pharmacia Corporation Oral liquid tolterodine composition
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
ATE432070T1 (de) * 2003-01-22 2009-06-15 Pfizer Health Ab Herabgesetzte dosis von tolterodin zur behandlung von harnwegserkrankungen
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
DK2210605T3 (en) 2003-11-04 2017-05-22 Tcd Royalty Sub Llc Daily single dose doses of trospium.
WO2005046663A1 (en) 2003-11-04 2005-05-26 Shire Laboratories, Inc. Compositions of quaternary ammonium containing bioavailability enhancers
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) † 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
JP2007527922A (ja) * 2005-01-10 2007-10-04 テバ ファーマシューティカル インダストリーズ リミティド 実質的に純粋なトルテロジンタルトレート及びその調製方法
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
HUE027282T2 (en) 2006-01-18 2016-11-28 Intec Pharma Ltd A method for preparing a dosing device for oral administration of the agent
CA2882048C (en) 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
KR100714058B1 (ko) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법
US20070202172A1 (en) * 2006-02-24 2007-08-30 Tomer Gold Metoprolol succinate E.R. tablets and methods for their preparation
MX2008011952A (es) * 2006-03-21 2008-10-01 Teva Pharma Formulacion de liberacion controlad de tolterodina.
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
JP2008007458A (ja) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd レイヤリング用核粒子とその製造方法
CA2670636A1 (en) 2006-11-27 2008-06-05 H. Lundbeck A/S Heteroaryl amide derivatives
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
ES2401205T3 (es) 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
CA2683514C (en) 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US20090017111A1 (en) * 2007-07-03 2009-01-15 Van Den Heuvel Dennie J M Tolterodine bead
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
CA2923102C (en) * 2007-08-13 2019-10-15 Omeho Life Sciences Inc. Abuse resistant drugs, method of use and method of making
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
KR101685031B1 (ko) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
WO2009140557A2 (en) * 2008-05-14 2009-11-19 Capricorn Pharma, Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2459180A1 (en) * 2009-07-31 2012-06-06 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN103037902A (zh) 2010-03-29 2013-04-10 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
MX341200B (es) 2010-03-29 2016-08-11 Ferring Bv Composicion farmaceutica de disolucion rapida.
AU2011245499B2 (en) 2010-04-30 2014-09-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120289560A1 (en) * 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (el) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
BR112014005134A2 (pt) 2011-09-16 2017-04-18 Ferring Bv composição farmacêutica de dissolução rápida
BR112014007753B1 (pt) * 2011-09-30 2021-07-06 Astellas Pharma Inc. composição farmacêutica granular, formulação e método para produção
EP3275466A1 (en) 2012-07-12 2018-01-31 Ferring B.V. Diclofenac formulations
MX2015003658A (es) * 2012-09-20 2015-09-25 Ohr Pharma Llc Microparticulas biodegradables de capas multiples para la liberacion sostenida de agentes terapeuticos.
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
WO2014159051A1 (en) * 2013-03-13 2014-10-02 Advanced Bionutrition Corp. Stable bioactive substances and methods of making
WO2014146093A2 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA2936741C (en) * 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
JP6924177B2 (ja) * 2016-02-23 2021-08-25 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤
EP4596045A3 (en) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Methods of vitamin d treatment
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPH07107450A (ja) 1993-10-08 1995-04-21 Hitachi Ltd 情報通信装置
JP3453186B2 (ja) 1994-04-14 2003-10-06 共和薬品工業株式会社 徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
CA2259012C (en) 1996-07-19 2008-05-13 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
TWI222879B (en) 2004-11-01
CZ20011627A3 (cs) 2001-10-17
HK1040917A1 (en) 2002-06-28
NO20012314D0 (no) 2001-05-10
HU226582B1 (en) 2009-04-28
SK284758B6 (sk) 2005-11-03
SK6252001A3 (en) 2002-01-07
HUP0105038A2 (en) 2002-06-29
PL195780B1 (pl) 2007-10-31
WO2000027364A1 (en) 2000-05-18
NO20012314L (no) 2001-07-09
PT1128819E (pt) 2003-12-31
CN1169522C (zh) 2004-10-06
AP1323A (en) 2004-11-05
IS2370B (is) 2008-06-15
EP1128819B1 (en) 2003-08-20
NZ511430A (en) 2003-05-30
ES2204193T3 (es) 2004-04-16
OA11673A (en) 2005-01-12
CN1326339A (zh) 2001-12-12
IL142809A0 (en) 2002-03-10
AU762410B2 (en) 2003-06-26
AR027815A1 (es) 2003-04-16
JP3616011B2 (ja) 2005-02-02
KR100467384B1 (ko) 2005-01-24
UA57165C2 (uk) 2003-06-16
BRPI9915142B1 (pt) 2015-08-25
US6911217B1 (en) 2005-06-28
PL348612A1 (en) 2002-06-03
BR9915142A (pt) 2001-08-07
SI1128819T1 (en) 2003-12-31
RS49891B (sr) 2008-08-07
ZA200103575B (en) 2002-05-03
HRP20010333A2 (en) 2003-04-30
YU33101A (sh) 2003-10-31
SE9803871D0 (sv) 1998-11-11
ATE247458T1 (de) 2003-09-15
HUP0105038A3 (en) 2006-07-28
HK1040917B (zh) 2005-05-27
EE05232B1 (et) 2009-12-15
EP1128819A1 (en) 2001-09-05
EA200100538A1 (ru) 2001-10-22
KR20010075695A (ko) 2001-08-09
AU1436600A (en) 2000-05-29
MY122195A (en) 2006-03-31
MA25325A1 (fr) 2001-12-31
NO331399B1 (no) 2011-12-19
EE200100254A (et) 2002-12-16
HRP20010333B1 (en) 2004-10-31
DK1128819T3 (da) 2003-12-01
DE69910604T2 (de) 2004-06-24
IS5936A (is) 2001-05-09
CZ299582B6 (cs) 2008-09-10
JP2003517446A (ja) 2003-05-27
CA2350061A1 (en) 2000-05-18
EA005074B1 (ru) 2004-10-28
TWI267385B (en) 2006-12-01
GEP20022833B (en) 2002-11-25
BG65149B1 (bg) 2007-04-30
BG105582A (en) 2001-12-29
DE69910604D1 (de) 2003-09-25
AP2001002166A0 (en) 2001-06-30
CA2350061C (en) 2005-05-17
BRPI9915142B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
ID18320A (id) Produk obat baru dan penggunaan daripadanya
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID26402A (id) Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya
DE69834972D1 (de) Plasma Anzeigetafel und Herstellungsverfahren derselben
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID28653A (id) Kolom gelembung udara dan penggunannya
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
ID22490A (id) Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
ID17128A (id) Granulat untuk pembuatan komposisi-komposisi cepat mengurai dan cepat larut yang mengandung jumlah obat yang tinggi
ID27558A (id) Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat
ID22283A (id) Kombinasi terapi baru dari zat-zat mirtazapin dan antipsikotik untuk perawatan atau propilaksis gangguan psikotik
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
ID24259A (id) Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol
ID18682A (id) Asiltransferase dan plasma yang mengkodekan asiltransferase
DE69420178D1 (de) Flüssigkeitsauftragegerät und Herstellung desselben
ID24716A (id) Formulasi baru
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
ID19147A (id) Ksilanase dan pemakaiannya
ID22416A (id) Komposisi-komposisi farmasi yang mengandung ibuprofen dan domperidon untuk pengobatan migrain
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
ID29871A (id) Turunan-turunan morfolin baru, metode pembuatannya dan komposisi-komposisi farmasi yang mengandungnya
ID23163A (id) Turunan-turunan piridina dan komposisi-komposisi farmasi yang mengandungnya